Brad Burris, MBA/MHA, has extensive experience in the healthcare and pharmaceutical industries, notably serving as Sr. Director at Pear Therapeutics from 2021 to 2023. Prior to this role, Brad held significant positions at multiple organizations, including National Account Executive at Actelion Pharmaceuticals and Corporate Account Director at InterMune Inc. Currently, Brad is the Director of National Accounts at Liquidia Corporation, where they focus on educating payers and fostering partnerships. Brad earned a Bachelor's degree from Appalachian State University and holds both an MBA and an MHA from Pfeiffer University.
This person is not in any teams
This person is not in any offices